{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_12668", "batch_size": 36, "batch_pos": 33, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment reports securing vaccines, handled by Q5.", "method": "llm_batch", "batch_id": "batch_2_17084", "batch_size": 188, "batch_pos": 185, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "Discusses securing vaccine doses, not the virus's impact, and contains 'secures', 'includes' (not moderate verbs).", "method": "llm_batch", "batch_id": "batch_3_17020", "batch_size": 104, "batch_pos": 101, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_16316", "batch_size": 98, "batch_pos": 95, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Mentions securing vaccines, but lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_20028", "batch_size": 90, "batch_pos": 87, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "'up to 665,000' and 'further 40 million' are not minimisers. No minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_16168", "batch_size": 29, "batch_pos": 26, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_20284", "batch_size": 189, "batch_pos": 186, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "The segment states 'The deal secures up to 665,000 doses... and includes an option for a further 40 million vaccines', describing securing vaccine doses (preparedness/resource acquisition), without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_20292", "batch_size": 183, "batch_pos": 180, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
